author-photo

George Chakhava

6

Papers

34

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Effects of Intravenous Eptinezumab vs Placebo on Headache Pain and Most Bothersome Symptom When Initiated During a Migraine Attack: A Randomized Clinical Trial.

2021 JAMA
Show All
- Source
- Cite
- Save
Citations (5)
Corrigendum to "Eptinezumab for the Prevention of Episodic Migraine: Sustained Effect Through 1 Year of Treatment in the PROMISE-1 Study" [Clin Therapeut 42 (12) (2020) 2254-2265].

2021 Clinical Therapeutics
Show All
- Source
- Cite
- Save
Citations (3)
Primary Results of PROMISE-1 (Prevention Of Migraine via Intravenous eptinezumab Safety and Efficacy–1) Trial: a Phase 3, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Eptinezumab for Prevention of Frequent Episodic Migraines (S20.001)

2018 Neurology
Show All
- Source
- Cite
- Save
Citations (17)